Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
To provide a safe, cost effective framework for Imported Unlicensed Medicines – medicines originating into the UK which has marketing authorisation and is licensed in the country of origin but does not have a UK marketing authorisation. This framework will provide centralised quality assurance for these medicines to ensure they are assessed in a safe, consistent manner and reducing duplication of assessments currently undertaken by individual Trusts
No supplier information available.
This procurement was divided into 1 lots, each awarded separately.
| Lot | Value | Status |
|---|---|---|
| Lot 1 Apr 2026 – Mar 2028 | - | planned |